Trial intelligence / Profile preview

Intravaginal APL-202 vs dinoprostone for induction of labour in multiparous women

2004-000108-42Phase 3Completed

Sponsor
Alliance Pharma
Start
May 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of misoprostol in induced labor (2 arms), sponsored by Alliance Pharma. Primary endpoint: Number of vaginal deliveries within 24 hours of the start of induction. Started May 2005; status: completed.

02

Drugs

misoprostol
03

Conditions

induced labor

Beyond the preview

Go deeper on 2004-000108-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-000108-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call